Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jared Weiss

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Cancer Medicine|December 8, 2022
Biomarkers predictive of response to pembrolizumab in head and neck cancerDavid G Pfister, Robert I Haddad, Francis P Worden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.
Nature Medicine|January 15, 2020
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alterationAlexander Drilon, Jeffrey W Clark, Jared Weiss, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2024
Determining Line of Therapy from Real-World Data in Non-Small Cell Lung CancerConnor B Grady, Wei-Ting Hwang, Joshua E Reuss, et al.
Nature Communications|May 20, 2018
Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linkingAlessandro Porrello, Patrick L Leslie, Emily B Harrison, et al.
Journal of the National Cancer Institute|November 21, 2019
PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified ChemoradiationBrian T Beaty, Dominic H Moon, Colette J Shen, et al.
Genome Medicine|June 15, 2021
Landscape and selection of vaccine epitopes in SARS-CoV-2Christof C Smith, Kelly S Olsen, Kaylee M Gentry, et al.
JTO Clinical and Research Reports|August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLCWilliam Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
JTO Clinical and Research Reports|January 6, 2025
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry AnalysisMargaret Stalker, Connor B Grady, Alex Watts, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2025
Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysisAdam Barsouk, Omar Elghawy, Alex Watts, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Cancer Medicine|December 8, 2022
Biomarkers predictive of response to pembrolizumab in head and neck cancerDavid G Pfister, Robert I Haddad, Francis P Worden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.
Nature Medicine|January 15, 2020
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alterationAlexander Drilon, Jeffrey W Clark, Jared Weiss, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2024
Determining Line of Therapy from Real-World Data in Non-Small Cell Lung CancerConnor B Grady, Wei-Ting Hwang, Joshua E Reuss, et al.
Nature Communications|May 20, 2018
Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linkingAlessandro Porrello, Patrick L Leslie, Emily B Harrison, et al.
Journal of the National Cancer Institute|November 21, 2019
PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified ChemoradiationBrian T Beaty, Dominic H Moon, Colette J Shen, et al.
Genome Medicine|June 15, 2021
Landscape and selection of vaccine epitopes in SARS-CoV-2Christof C Smith, Kelly S Olsen, Kaylee M Gentry, et al.
JTO Clinical and Research Reports|August 19, 2024
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLCWilliam Tompkins, Connor B Grady, Wei-Ting Hwang, et al.
JTO Clinical and Research Reports|January 6, 2025
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry AnalysisMargaret Stalker, Connor B Grady, Alex Watts, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2025
Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysisAdam Barsouk, Omar Elghawy, Alex Watts, et al.
Pageof 10